MTUM iShares MSCI USA Momentum Factor ETF

Expense Ratio
0.15%
Dividend
0.67%
Previous close
$294.32
Est. 12 months change
-27.09%
Projected Price
$214.58

Profitability Metrics

Return on Equity (ROE)
37.05%
Return on Assets (ROA)
12.39%
Return on Invested Capital (ROIC)
36.18%
Weighted Average Cost of Capital (WACC)
11.04%
ROIC - WACC
25.14%
Updated : 2026-05-18 21:31 ET

Valuation Metrics

P/E Ratio
33.23
Forward P/E
22.25
PEG Ratio
1.57
Debt Current Ratio
2.12

Growth & Cash Flow

Gross Margin
50.37%
Operating Margin
27.20%
FCF Margin
21.99%
TTM Revenue Growth
38.39%
Projected 12M EPS Growth
49.33%

Price Change

Price % from 50 SMA
10.35%
Price % from 200 SMA
15.41%
6 Months
21.60%
1 Year
27.59%
2 Years
57.05%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
MU7.74%
AVGO5.27%
NVDA5.08%
AMD4.74%
INTC4.36%
LRCX3.89%
JNJ3.50%
XOM3.15%
CAT3.08%
GOOGL2.85%

ETF Analysis

Fund Overview

iShares MSCI USA Momentum Factor ETF (MTUM) currently reports 124 stock positions (subject to change), placing it in the broadly constructed range by holdings breadth. The top line-up is MU (7.74%), AVGO (5.27%), NVDA (5.08%), with MU as the largest single weight at 7.74%. Together, the top three holdings account for 18.09%, which suggests the fund is not overly reliant on its largest positions to generate returns. The fund's architecture positions it to benefit from strength in its top holdings while the broader basket provides a degree of insulation against single-name shocks.

Profitability & Capital Efficiency

Looking at how effectively the underlying holdings deploy capital, ROIC is 36.18%, WACC is 11.04%, and the economic spread is 25.14%. On balance, holdings are earning returns on capital well in excess of what investors and creditors require — the defining characteristic of a high-quality compounding portfolio. Supporting metrics show ROE at 37.05% and ROA at 12.39%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

On an earnings multiple basis, trailing P/E of 33.23, forward P/E of 22.25, PEG of 1.57. Forward P/E sits materially below trailing P/E, which supports the view that earnings expectations are improving and the basket looks cheaper on forward numbers. The PEG ratio sits in a range that most investors would consider fair — neither cheap nor obviously stretched relative to anticipated earnings. A current ratio reading of 2.12 points to holdings that are managing short-term obligations without apparent stress. Combining multiples and liquidity, the portfolio appears adequately priced for its current earnings trajectory, with balance sheet health providing a degree of downside resilience.

Margins & Cash Generation

Across the three margin layers, gross margin sits at 50.37%, operating margin at 27.20%, and free cash flow margin at 21.99%. Gross margins sit in a healthy range, consistent with businesses that manage input costs effectively. Operating margins are in good shape, consistent with businesses that maintain reasonable earnings conversion after overhead. At this level, free cash flow margins suggest businesses that are building financial strength alongside revenue growth. Read together, these margins describe businesses that have earned their profitability rather than manufactured it through accounting — a meaningful quality signal.

Growth & Forward Outlook

On a forward-looking basis, TTM revenue growth of 38.39% a signal of strong operational momentum across the holding set, while the estimated 12-month price change of -27.36%, where implied returns are negative based on the present target distribution. Revenue growth and price targets are correlated but not the same — strong operations do not always translate to strong price appreciation, and vice versa. The forward return case rests on whether the businesses can sustain their operating trajectory long enough for analyst price targets to be reached or exceeded. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Balancing the strengths against the areas of uncertainty, the weight of evidence favors an optimistic view with appropriate risk awareness.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.